Homecrux went hands-on at Europe's biggest tech show. From robot pool cleaners to AI tennis partners, here's what actually ...
XPPen has unveiled the Magic Pro 13, a 2-in-1 drawing pad that combines mobile creativity with professional desktop drawing ...
At IFA 2026 in Berlin, XPPen is introducing its latest Android drawing tablet, the Magic Pro 13. The brand claims that this ...
The U.S. Food and Drug Administration has authorized Aletta as the first standalone robotic device that can draw blood from a patient's arm. Marketing authorization was granted to Vitestro. The device ...
THURSDAY, Aug. 20, 2026 (HealthDay News) -- The U.S. Food and Drug Administration has authorized the Aletta as the first standalone robotic device that can draw blood from a patient's arm. The device ...
WASHINGTON (dpa-AFX) - The U.S. Food and Drug Administration has authorized Aletta, the first standalone robotic device that can draw blood from a patient's arm without hands-on operator intervention.
The FDA has approved Vitestro’s Aletta as the first standalone robotic device in the U.S. designed to draw blood without the need for hands-on human help. The approval, the FDA said in a release, will ...
The Food and Drug Administration granted marketing authorization to Vitestro for Aletta, a robotic blood draw device. The FDA said the Aletta is the first standalone robotic device that can draw blood ...
Add Yahoo as a preferred source to see more of our stories on Google. The FDA authorized Aletta, the first standalone robotic device that can draw blood from an adult patient's arm without hands-on ...
The FDA authorized Aletta, the first standalone robotic device that can draw blood from an adult patient’s arm without hands-on operator intervention. The robot finds a suitable vein and autonomously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results